Dr. Raman Tuli
Participe à 2 sessions
Sessions auxquelles Dr. Raman Tuli participe
3:50 PM
3:50 PM
- Faricimab in Neovascular Age-Related Macular Degeneration: One-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials
- Conférencier.ère Dr. Raman Tuli |
- 3:51 PM - 3:59 PM | 8 minutes Partie de: Rétine I
- Authors: Raman Tuli, 1.Carlos Quezada Ruiz, 2.David Silverman, 3.Vaibhavi Patel, 4.Karen Basu, 5.Hugh Lin.
- Paper Presentation | Présentation d'article
4:05 PM
4:05 PM
- Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab(PDS) for Patients With Neovascular AMD
- Conférencier.ère Dr. Raman Tuli |
- 4:07 PM - 4:15 PM | 8 minutes Partie de: Rétine II
- Authors: Raman Tuli, Peter A. Campochiaro, Natasha Singh, David Kardatzke, Steven Blotner, Shienal Patel, Giulio Barteselli.
- Paper Presentation | Présentation d'article